Corline Biomedical AB Reports Earnings Results for the First Quarter Ended March 31, 2022
May 13, 2022 at 02:45 am EDT
Corline Biomedical AB reported earnings results for the first quarter ended March 31, 2022. For the first quarter, the company reported sales was SEK 4.42 million compared to SEK 2.75 million a year ago. Revenue was SEK 4.53 million compared to SEK 2.76 million a year ago. Net loss was SEK 0.852 million compared to SEK 1.4 million a year ago. Basic loss per share from continuing operations was SEK 0.04 compared to SEK 0.08 a year ago. Diluted loss per share from continuing operations was SEK 0.04 compared to SEK 0.08 a year ago.